Clinicopathological features and prognosis of patients with HER2-low breast cancer

Clinicopathological features and prognosis of patients with HER2-low breast cancer

Abstract Background Low human epidermal growth factor receptor 2 (HER2) expression is an emerging concept in breast cancer that is defined as immunohistochemistry (IHC) 1 + or IHC 2 + and negative in situ hybridization (ISH) but has been poorly investigated. The aim of our study was to determine the...

Full description

Bibliographic Details
Main Authors: Xin Yang, Yao Li, Xu lu, Xiaotian Ren, Bin Hua
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Cancer
Subjects:
Breast cancer
HER2-low expression
Clinicopathological features
Prognosis
Online Access:https://doi.org/10.1186/s12885-023-11421-0

Similar Items

Similar Items